AGENT OF BACTERICIDE ACTION IN RELATES TO VEGETATIVE AND SPORE CELLS Bacillus anthracis, METHOD FOR MALIGNANT ANTHRAX PROPHYLAXIS AND TREATMENT

FIELD: biotechnology, medicine, veterinary, in particular inhibition of vegetative and spore cell (Bacillus anthracis) vitality and malignant anthrax prophylaxis. ^ SUBSTANCE: invention relates to agent of bactericide action in relates to vegetative spore cells Bacillus anthracis. Agent contains bac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHISHKOVA NINA ANDREEVNA, MARININ LEONID IVANOVICH, TSFASMAN IRINA MATVEEVNA, STARITSIN NIKOLAJ ANDREEVICH, STEPNAJA OL'GA ANDREEVNA, CHAJKA IRINA ALEKSANDROVNA, KULAEV IGOR' STEPANOVICH, BEGUNOVA ELENA AL'BERTOVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: biotechnology, medicine, veterinary, in particular inhibition of vegetative and spore cell (Bacillus anthracis) vitality and malignant anthrax prophylaxis. ^ SUBSTANCE: invention relates to agent of bactericide action in relates to vegetative spore cells Bacillus anthracis. Agent contains bacteriolytic complex produced by Lysobacter sp.XL1. In method for malignant anthrax prophylaxis bacteriolytic complex produced by abovementioned bacterium strain is used as active ingredient. Said method includes subdermal injection in one dose not later than 3 hours after contamination, or application of dressing (drape) impregnated with active ingredient on place of possible exciter penetration, or treatment of possible contamination focus with aerosol. ^ EFFECT: bactericide agent without side effects and decreased prophylaxis time. ^ 6 cl, 8 ex, 8 tbl